Problem: Genome Data Held in Silos, Unshared, not Standardized for Exchange
|
|
- Katherine Thomasina Hodges
- 7 years ago
- Views:
Transcription
1 Problem: Genome Data Held in Silos, Unshared, not Standardized for Exchange No one institute has enough on its own to make progress. Every researcher and clinician should be able to compare their genome data to others.
2 We need a public ledger for sharing GATTTATCTGCTCTCGTTG GAAGTACAAAATTCATTAAT GCTATGCACAAAATCTGTAG C TAGTGTCCCATCTATTT
3 Alliance for data sharing UC Santa Cruz Genomics Institute
4 Enabling Responsible Sharing of Genomic and Clinical Data GA4GH Founded on June 5, 2013 More than 400 insitu:onal members From more than 40 countries, Approx. 1/3 are companies Mission: to enable rapid progress in biomedicine Strategy: support major driver projects create and maintain interoperability of technology plajorm standards develop guidelines and harmonizing procedures for privacy and ethics in the interna:onal regulatory context engage stakeholders across sectors to encourage the responsible and voluntary sharing of data and of methods
5 Cancer Global Data Sharing Cancer is driven by muta8ons in DNA. Precision treatment of cancer depends on knowledge of these muta8ons Start with a Pilot: -build a mechanism for recording cancer DNA muta:ons and clinical informa:on from millions of cancer pa:ent par:cipants across the world -Ini:ally called the Ac:onable Cancer Genome Ini:a:ve -Cancer is the right place to start. Once this is working, similar technology could be used to share DNA informa:on for other diseases genomicsandhealth.org
6 Example proposed public record gene: BRAF variant: V600E Pa:ent ID: 163a fa-4705-bc\-d264c4cff796 Gender: Male Ethnicity: White Caucasian Age at Diagnosis: 57 Tumor Classifica:on: non-small-cell lung carcinoma (MeSH D002289) Tissue or organ of origin: Lung Tumor morphology: Squamous (epidermoid)
7 Data Sharing Specifica:ons Data open and available to all Ubiquitously accessible on the Internet Can scale to accept dona:ons from 1000s of sources Not maintained by any central authority or :ed to any single country, loca:on or ins:tu:on Not corrup:ble Protects par:cipant privacy Stable design so that it may be used by many 3 rd party applica:on programs ( apps )
8 This is accomplished with a Shared Public Ledger Ethereum: foundation Ripple: Hyperledger: hyperledger IBM Open BlockChain: MIT Enigma project enigma.media.mit.edu AirBnB (proposed):
9 Simplest Shared Public Ledger Record of transac8ons over :me Transac:on is adding informa:on to the database Special case: New informa:on marks previous informa:on as out-of-date It is only possible to add more transac:ons, no transac:on is ever erased or altered 1000s of copies of the ledger all over the world are kept in sync while addi:onal transac:ons come in from mul:ple sources by miners A shared public ledger keeps track of data provenance, i.e. when and how data was entered and updated, so users have the reputa:on/ reliability informa:on they need to filter out data they don t want
10 Ethereum Cancer KnowLedger Pilot Website at findpubs.org See:
11 Who will use the shared public ledger? Shared Public Ledger???? Data Users are: Professional Researchers Ci:zen Scien:sts Clinicians Developers of molecular dx, drugs, decision analysis tools Payers Pa:ents/par:cipants Regulatory agencies and treatment guideline organiza:ons
12 Where do the data come from???????? Ul:mately, all data comes from individual par8cipants who wish to share their gene:c and clinical informa:on for research or improvement of medicine??
13 How do data enter the ledger? Researchers Clinicians par:cipants? Shared Public Ledger Individuals Developers
14 A par:cipant works with a Trusted Steward to add their informa:on to the ledger
15 Possible Trusted Stewards Medical research ins:tu:ons (e.g. GENIE ins:tu:ons) Hospitals and clinics Pa:ent registry services and clinical trial recruitment organiza:ons Pa:ent agency advocate groups possibly providing service to allow pa:ents to maintain agency over data AND par:cipate in clinical trials (e.g. Sage Trust and Gene:c Alliance) Gene:c tes:ng companies All trusted stewards use the same somware (provided by GA4GH) to add informa:on to the ledger System is designed to support thousands of stewards globally
16 Trusted Stewards Data Users Medical Clinics Researchers par:cipants Pa:ent Advocacy Groups Pa:ent Registries Shared Public Ledger Clinicians Developers Tes:ng Companies Individuals
17 What goes into the public ledger and what stays with the steward? Public Ledger Par:cipant s gene:c variants in selected genes ~1 dozen broad, noniden:fying clinical features Steward s iden:ty and contact info Random numerical ID for par:cipant Steward Par:cipant personal iden:fying informa:on and staged consent Par:cipant s extended clinical and gene:c info Possibly iden:fying Par:cipant s instruc:ons for sharing addl info with qualified researchers w/o recontact Par:cipant s instruc:ons for recontact
18 Example: par:cipant -> public ledger Par:cipant visits doctor at a medical clinic Doctor orders gene:c test Doctor suggests data dona:on through steward (possibly her own ins:tu:on) Test results come back
19 Test Results
20 Par:cipant visits steward Steward records from the par:cipant: personal informa:on test results addi:onal gene:c and clinical data consent to donate to database addi:onal sharing and recontact preferences Steward appends par:cipant s publicly sharable gene:c/clinical data to public ledger
21 Trusted Stewards Data Users Medical Clinics Researchers par:cipants Pa:ent Advocacy Groups Pa:ent Registries Shared Public Ledger Clinicians Developers Tes:ng Companies Individuals
22 Recontact Data user discovers muta:ons of interest by using 3 rd party app on the public ledger and wants more informa:on about the par:cipant that provided in the ledger Data user contacts par:cipant s steward Steward has info about under what circumstances the par:cipant will share addi:onal data or agrees to be recontacted As appropriate, steward will supply addi:onal informa:on to data user or set up contact between user and par:cipant
23 Trusted Stewards Data Users Medical Clinics Third-Party App Researchers par:cipants Pa:ent Advocacy Groups Pa:ent Registries Shared Public Ledger Clinicians Developers Tes:ng Companies Individuals
24 How do two stewards know if they have a par:cipant in common? On the public ledger, a par:cipant is iden:fied with a random number Each steward securely stores personal iden:fiable informa:on for their par:cipants; only they can associate par:cipant with a public random number Personal iden:fiable informa:on is compared between the two stewards without revealing any informa:on except which par:cipants they have in common by a cryptographic trick (secure mul:party computa:on) To make it comparable, personal information could be collected by the NIH NDAR GUID standard
25 Demo: secure mul:party computa:on to compute private set intersec:on Internet Homomorphic encryption Steward A 100,000 participants 10 overlap with B Steward B 100,000 participants 10 overlap with A Neither server sees the personal information on the other. Only the checksum identifying the participants in common is visible, nothing else Runtime: 10 seconds over a transatlantic link, single CPU Implementation and experiments by Max Haeussler
26 Who can be a steward? Any en:ty that: Has a legi:mate permanent contact Follows the rules Has enough par:cipants to prevent par:cipant reiden:fica:on by steward (small stewards can be anonymously pooled) All stewards will have Internet ra:ngs; these can be available on a ledger (e.g. like AirBnB); users can filter out unreliable steward data
27 Who pays for all this? System can be designed and implemented for a few million dollars; long term maintenance is the only issue Governments or philanthropies (possibly associated with hospitals, pa:ent advocacy groups, etc.) could supply general funding Taxes on gene:c tests could provide revenue Stewards can be mo:vated to secure data dona:ons either by altruism or commissions from data users 3 rd party app developers can charge for use of their tools or sell adver:sing to support their efforts and to support the public ledger
28 Summary A completely decentralized, public database is possible, while s:ll protec:ng privacy We need this because trust is local No single state government or private organiza:on can/should own or control all the world s gene:c data Once launched, a shared public ledger grows and is maintained organically by the global community because it benefits them, much like the Internet itself
Research Data Networks: Privacy- Preserving Sharing of Protected Health Informa>on
Research Data Networks: Privacy- Preserving Sharing of Protected Health Informa>on Lucila Ohno-Machado, MD, PhD Division of Biomedical Informatics University of California San Diego PCORI Workshop 7/2/12
More informationNCDS Leadership Summit " The Friday Center" Chapel Hill, North Carolina" April 23 & 24, 2013!
NCDS Leadership Summit " The Friday Center" Chapel Hill, North Carolina" April 23 & 24, 2013! Data Collection Scale of Problem Challenges v Research versus clinical contexts v Science versus medicine v
More informationPu?ng B2B Research to the Legal Test
With the global leader in sampling and data services Pu?ng B2B Research to the Legal Test Ashlin Quirk, SSI General Counsel 2014 Survey Sampling Interna6onal 1 2014 Survey Sampling Interna6onal Se?ng the
More informationCSER & emerge Consor.a EHR Working Group Collabora.on on Display and Storage of Gene.c Informa.on in Electronic Health Records
electronic Medical Records and Genomics CSER & emerge Consor.a EHR Working Group Collabora.on on Display and Storage of Gene.c Informa.on in Electronic Health Records Brian Shirts, MD, PhD University of
More informationBroadband Success & Struggles in Healthcare
Broadband Success & Struggles in Healthcare Broadband is important to providing telehealth in rural healthcare facili9es Telehealth requires reliable broadband connec9on Healthcare facili9es seeing a change
More informationTop Practices in Health IT Compliance. Data Breach & Leading Program Prac3ces
Top Practices in Health IT Compliance Data Breach & Leading Program Prac3ces Overview Introduc3on to ID Experts & Secure Digital Solu3ons Healthcare Data Breach Trends & Drivers Data Incident Management
More informationIf you are signing for a minor child, you refers to your child throughout the consent document.
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY Adult Patient or Parent, for Minor Patient INSTITUTE: National Cancer Institute PRINCIPAL INVESTIGATOR: Raffit Hassan, M.D. STUDY TITLE: Tissue Procurement
More informationPa#ent Involvement in Clinical Research In Rela#onship with Biobanking BBMRI 15 December 2009
Pa#ent Involvement in Clinical Research In Rela#onship with Biobanking BBMRI 15 December 2009 Cor Oosterwijk Project Coordinator Pa;entPartner Dutch Gene;c Alliance VSOP European Gene;c Alliances Network
More informationA Guide to Clinical Trials
A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.
More informationGlobal Alliance for Genomics & Health Data Sharing Lexicon
Global Alliance for Genomics & Health Data Sharing Lexicon Preamble The Global Alliance for Genomics and Health ( GA4GH ) is an international, non-profit coalition of individuals and organizations working
More informationNOW!! Registry and BioBank Services for! Your Organization/Company/Clinic/Project!
NOW!! Registry and BioBank Services for! Your Organization/Company/Clinic/Project! What Does Genetic Alliance Registry and BioBank Offer?! Flexible, customizable, registry and biobank options One-on-one
More informationProtec'ng Informa'on Assets - Week 8 - Business Continuity and Disaster Recovery Planning. MIS 5206 Protec/ng Informa/on Assets Greg Senko
Protec'ng Informa'on Assets - Week 8 - Business Continuity and Disaster Recovery Planning MIS5206 Week 8 In the News Readings In Class Case Study BCP/DRP Test Taking Tip Quiz In the News Discuss items
More informationIMPACT OF THE NEW ICD- 10 CODING SYSTEM ON THE MEDICAL BILLING AND PAYMENT PROCESS
IMPACT OF THE NEW ICD- 10 CODING SYSTEM ON THE MEDICAL BILLING AND PAYMENT PROCESS ICD- 10 Acronym Interna(onal Classifica(on of Diseases Tenth Revision ICD- 10 Basic Facts Replaces ICD- 9 Five digit coding
More informationFrom Open Access, to Controlled, to Registered Access?
From Open Access, to Controlled, to Registered Access? Prof. Bartha M. Knoppers Canada Research Chair in Law and Medicine Chair of the GA4GH Regulatory and Ethics Working Group Dr. Stephanie O.M. Dyke
More informationUpdate on the Cloud Demonstration Project
Update on the Cloud Demonstration Project Khalil Yazdi and Steven Wallace Spring Member Meeting April 19, 2011 Project Par4cipants BACKGROUND Eleven Universi1es: Caltech, Carnegie Mellon, George Mason,
More informationConsent Form: Example 2 (DNA Sequencing)
Consent Form: Example 2 (DNA Sequencing) Important note: This model language was developed for the NHGRI Medical Sequencing Project (MSP). It is included here only as an example of how to describe a sequencing
More informationInterna'onal Standards Ac'vi'es on Cloud Security EVA KUIPER, CISA CISSP EVA.KUIPER@HP.COM HP ENTERPRISE SECURITY SERVICES
Interna'onal Standards Ac'vi'es on Cloud Security EVA KUIPER, CISA CISSP EVA.KUIPER@HP.COM HP ENTERPRISE SECURITY SERVICES Agenda Importance of Common Cloud Standards Outline current work undertaken Define
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationUAB Cyber Security Ini1a1ve
UAB Cyber Security Ini1a1ve Purpose of the Cyber Security Ini1a1ve? To provide a secure Compu1ng Environment Individual Mechanisms Single Source for Inventory and Asset Management Current Repor1ng Environment
More informationLUNG CANCER CLINICAL TRIALS
UNDERSTANDING LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 TABLE OF CONTENTS INTRODUCTION TO CLINICAL TRIALS What Is a Clinical Trial?...4 Types of Clinical
More informationDTCC Data Quality Survey Industry Report
DTCC Data Quality Survey Industry Report November 2013 element 22 unlocking the power of your data Contents 1. Introduction 3 2. Approach and participants 4 3. Summary findings 5 4. Findings by topic 6
More informationDelivery date: 18 October 2014
Genomic and Clinical Data Sharing Policy Questions with Technology and Security Implications: Consensus s from the Data Safe Havens Task Team Delivery date: 18 October 2014 When the Security Working Group
More informationUpdate on the Cloud Demonstration Project
Update on the Cloud Demonstration Project Steven Wallace Joint Techs Summer 2011 13- July- 2011 Project Par4cipants BACKGROUND Twelve Universi,es: Caltech, Carnegie Mellon,Cornell George Mason, Indiana
More informationHands On- Google Grants Google Adwords for Non- Pro5its
Hands On- Google Grants Google Adwords for Non- Pro5its Search Adver5sing Approach and Strategy Katherine Cleland ClelandMarke5ng 1 Why Google Adwords? Online Search has replaced Yellow Pages 80% of online
More informationGeoff McGregor, Indiana University Integra(ng KC with CAS and LDAP 4/25/2012
2012 User Conference April 22-24, 2012 Atlanta, Georgia Together Toward Tomorrow Geoff McGregor, Indiana University Integra(ng KC with CAS and LDAP 4/25/2012 open source administration software for education!
More information1. General Information About The Mitochondrial Disease Biobank
Name and Clinic Number IRB # 09-002265 00 Consent form approved November 6, 2013; This consent valid through August 6, 2014; 1. General Information About The Mitochondrial Disease Biobank Study Title:
More informationTransla6ng from Clinical Care to Research: Integra6ng i2b2 and OpenClinica
Transla6ng from Clinical Care to : Integra6ng i2b2 and OpenClinica Aaron Abend Managing Director, Recombinant Data Corp May 13, 2011 Copyright 2011 Recombinant Data Corp. All rights reserved. 1 About Recombinant
More informationWorldwide Collaborations in Molecular Profiling
Worldwide Collaborations in Molecular Profiling Lillian L. Siu, MD Director, Phase I Program and Cancer Genomics Program Princess Margaret Cancer Centre Lillian Siu, MD Contracted Research: Novartis, Pfizer,
More informationHIPAA Basics. Health Insurance Portability and Accountability Act of 1996
HIPAA Basics Health Insurance Portability and Accountability Act of 1996 HIPAA: What Is HIPAA? Protects the privacy of healthcare informa@on for all Americans, including the individuals you support Protects
More informationHIPAA Privacy Policy (Revised Feb. 4, 2015)
Valley Bone & Joint Clinic HIPAA Privacy Policy (Revised Feb. 4, 2015) 1. PURPOSE Valley Bone & Joint Clinic is commi2ed to protec6ng the rights of our pa6ents. In compliance with the Health Insurance
More informationCommonwealth Advanced Data Analytics Alliance & The President s Precision Medicine Initiative
Commonwealth Advanced Data Analytics Alliance & The President s Precision Medicine Initiative Deputy Secretary Anthony Fung Presentation to the Health IT Standards Advisory Committee December 17, 2015
More informationInformation for patients and the public and patient information about DNA / Biobanking across Europe
Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes
More informationThe Power of Positive Voices
The Power of Positive Voices Todays Webinar Will Explore: Background on posi8ve organizing and meaningful involvement of people living with HIV; The power of posi8ve voices to change the course of the
More informationThe Billion Dollar Product Online Privacy. Rui Miguel Feio Security Lead RSM Partners
The Billion Dollar Product Online Privacy Rui Miguel Feio Security Lead RSM Partners Agenda Introduc.on Free online services Nothing in life is for free Paid online web services How do they do it? Risks
More informationHOW HEALTH LITERACY WILL BE DEFINED IN FUTURE.
HOW HEALTH LITERACY WILL BE DEFINED IN FUTURE. EPATIENTS, EHEALTH SERVICES AND EHEALTH LITERACY THE FORGOTTEN CORNER STONES OF CONTEMPORARY HEALTH LITERACY RESEARCH. EHEALTH LITERACY Defini0on from Norman/Skinner
More informationEngaging and Communica-ng with Pa-ents and Providers. Constituent Experience
Engaging and Communica-ng with Pa-ents and Providers Constituent Experience Welcome Panel Jenny Whitham, Director of Information Technologies, North Dakota Department of Human Services Thangappan Patturajah,
More informationWebinar: Having the Best of Both World- Class Customer Experience and Comprehensive Iden=ty Security
Webinar: Having the Best of Both World- Class Customer Experience and Comprehensive Iden=ty Security With Iden>ty Expert and UnboundID Customer Bill Bonney Today s Speakers Bill Bonney Formerly Director,
More informationGenes for Good Consent Form
Genes for Good Consent Form Version 2.1 The next few screens contain information about Genes for Good and the benefits and risks of participating. This is called "informed consent", because we want you
More informationGenetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010
Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Liz Horn Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1872/geneticalliancebiobank:avirtualto
More informationA guide for the patient
Understanding series LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS The Basics What is a Clinical Trial?...3 Types of Clinical Trials... 3 Phases
More informationData Privacy and Data Security in Telemedicine Applica5ons. Patrick Harpes www.monitor it.lu
Data Privacy and Data Security in Telemedicine Applica5ons Patrick Harpes www.monitor it.lu Agenda Right to privacy Data/Informa@on security Data security measures Risks using telemedicine Composi@on of
More informationHow does a kidney transplant differ from dialysis?
TA L K I N G A B O U T T R A N S P L A N TAT I O N Frequently Asked Questions about Kidney Transplant Evaluation and Listing If your kidneys have stopped working properly, or may stop working soon, you
More informationWhy do we do what we do?
Why do we do what we do? Dissemina/on of Prac/ce Doctorate Scholarship: Impact Needed Julee Waldrop, DNP, FAANP School of Nursing University of North Carolina Flip Side: Research 1 3/26/15 How Do We Communicate
More informationPoten&al Impact of FDA Regula&on of EMRs. October 27, 2010
Poten&al Impact of FDA Regula&on of EMRs October 27, 2010 Agenda The case for regula&ng Impact on manufacturers Impact on providers Recommenda&ons and best prac&ces 2 A Medical Device Is an instrument,
More informationPu#ng together a bioinforma1cs team: 2014 compared with 1997
Pu#ng together a bioinforma1cs team: 2014 compared with 1997 BIG DATA and Healthcare Analy3cs Melbourne, Thursday 3 rd April 2014 Terry Speed, Walter & Eliza Hall Ins3tute of Medical Research 1 Overview
More informationAgenda. What Data Science Can Learn from Training in Biomedical Informa8cs: The OHSU Experience
What Data Science Can Learn from Training in Biomedical Informa8cs: The OHSU Experience William Hersh, MD, FACP, FACMI Professor and Chair Department of Medical Informa8cs & Clinical Epidemiology Oregon
More informationClinical Cancer Genomes. on behalf of the GA4GH Clinical Working Group
Clinical Cancer Genomes Mark Lawler (Queen s University Belfast and GA4GH Clinical Working Group) on behalf of the GA4GH Clinical Working Group Disclosure Statement Disclosure Statement I have nothing
More informationInnovation: Present Meets Future
Innovation: Present Meets Future SOCIAL INNOVATION Leading Innovation in the Cooperative Group Setting Craig Nichols, M.D. BEST OF SWOG Barlogie-Salmon Myeloma Committee Robert Z. Orlowski, M.D., Ph.D.
More informationDisrup've Innova'ons Track
Disrup've Innova'ons Track Product Disrup-ons: Medical Device Cybersecurity Presenter: Adam Brand, Associate Director, Pro-vi- V. 1.1 FACULTY DISCLOSURE The faculty reported the following financial relationships
More informationThe NIH Roadmap: Re-Engineering the Clinical Research Enterprise
NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before
More informationtargeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
More informationDigital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
More informationClinical Trials at PMH
Clinical Trials at PMH What You Need To Know UHN Patient Education Improving Health Through Education A Guide for Patients, Their Families and Friends in the PMH Cancer Program This information is to be
More informationPrivacy- Preserving P2P Data Sharing with OneSwarm. Presented by. Adnan Malik
Privacy- Preserving P2P Data Sharing with OneSwarm Presented by Adnan Malik Privacy The protec?on of informa?on from unauthorized disclosure Centraliza?on and privacy threat Websites Facebook TwiFer Peer
More informationThe 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
More informationA Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.
A Source of Hard- to- Find Pa3ents and Caregivers For Researchers Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.com About RPV Rare Pa3ent Voice, LLC was formed to provide
More informationHIPAA Compliance and Electronic Protected Health Informa6on: Ignorance is not bliss!
Maxxum, Inc. HIPAA Compliance and Electronic Protected Health Informa6on: Ignorance is not bliss! Medical Device ephi Risk Iden6fica6on and Mi6ga6on Webinar Overview Relevance why this topic? Risk a perspective
More informationndna Tim Hughes Avdeling for Medisinsk Gene@kk Oslo Universitets Sykehus (Ullevål)
ndna Utvikling av nasjonal analyse- og lagringspla3orm for DNA sekvensdata i helsevesenet Tim Hughes Avdeling for Medisinsk Gene@kk Oslo Universitets Sykehus (Ullevål) My goal Present the ndna project
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationMission. To provide higher technological educa5on with quality, preparing. competent professionals, with sound founda5ons in science, technology
Mission To provide higher technological educa5on with quality, preparing competent professionals, with sound founda5ons in science, technology and innova5on, commi
More informationDEFINING COMPONENTS OF NATIONAL REDD+ FINANCIAL PLANNING
DEFINING COMPONENTS OF NATIONAL REDD+ FINANCIAL PLANNING WORKSHOP ON BUILDING MULTI- SOURCE REDD+ FINANCING STRATEGIES Antigua, Guatemala July 17 and 18, 2014 Objec'ves of REDD+ Financial Planning Financial
More informationWelcome Address by the. State Secretary at the Federal Ministry of Education and Research. Dr Georg Schütte
Welcome Address by the State Secretary at the Federal Ministry of Education and Research Dr Georg Schütte at the "Systems Biology and Systems Medicine" session of the World Health Summit at the Federal
More informationProtec'ng Informa'on Assets - Week 10 - Identity Management and Access Control. MIS 5206 Protec/ng Informa/on Assets Greg Senko
Protec'ng Informa'on Assets - Week 10 - Identity Management and Access Control In the News Readings MIS5206 Week 10 Identity Management and Access Control Test Taking Tip Quiz In the News Discuss items
More informationTAKING PART IN CANCER TREATMENT RESEARCH STUDIES
For more infomation about Cancer Clinical Trials at Upstate Cancer Center please call Upstate Connect 1.800.464.8668 TAKING PART IN CANCER TREATMENT RESEARCH STUDIES Information provided by: National Cancer
More informationORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS INCORPORATE GENOMIC DATA INTO CLINICAL R&D KEY BENEFITS Enable more targeted, biomarker-driven clinical trials Improves efficiencies, compressing
More informationGENETICS AND GENOMICS IN NURSING PRACTICE SURVEY
GENETICS AND GENOMICS IN NURSING PRACTICE SURVEY Dear Registered Nurse: You are invited to take a survey that will evaluate primary issues in genetics and genomics. As the front line of care, nurses have
More informationThe Importance of Sharing Medical Data
Diving into the Data Pool Exploring public views about the way medical data is shared Report from public event on 31 October 2013 Should it be easier for medical data to be shared to help research? What
More informationCloud, and Digital Iden1ty Management (DIM) Exis1ng DIMs and their Limita1ons Our Goals World of Group Signatures SPICE!
Cloud, and Digital Iden1ty Management (DIM) Exis1ng DIMs and their Limita1ons Our Goals World of Group Signatures SPICE! Simple Showcase 2 Cloud compu1ng has been envisioned as the next- genera1on architecture
More informationNational Cancer Institute
National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Taking Part in Cancer Treatment Research Studies If
More informationAdventures in Bouncerland. Nicholas J. Percoco Sean Schulte Trustwave SpiderLabs
Adventures in Bouncerland Nicholas J. Percoco Sean Schulte Trustwave SpiderLabs Agenda Introduc5ons Our Mo5va5ons What We Knew About Bouncer Research Approach & Process Phase 0 Phase 1 7 Final Test What
More informationBig Data An Opportunity or a Distraction? Signal or Noise?
Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28
More informationClinical Trials: Questions and Answers
Clinical Trials: Questions and Answers Key Points Clinical trials are research studies that test how well new medical approaches work in people (see Question 1). Every clinical trial has a protocol, which
More informationVision of Interoperability Jamie Ferguson, Stan Huff, Cris Ross
Vision of Interoperability Jamie Ferguson, Stan Huff, Cris Ross Evolu&on of Interoperability As HIE evolves, the interoperability framework standards advance for reliable exchange and data integra=on across
More informationRetaining and Preserving the Scholarly Record: An Update on the Eastern Academic Scholars Trust
Retaining and Preserving the Scholarly Record: An Update on the Eastern Academic Scholars Trust Susan Stearns, Execu?ve Director Boston Library Consor?um sstearns@blc.org From NERD to EAST Ini?al planning
More informationSyndromic Surveillance BioSense Onboarding in Arizona
Syndromic Surveillance BioSense Onboarding in Arizona Sara Imholte, Stanley Kotey, Manoj Shaw & Krystal Collier Electronic Disease Surveillance Program April 1, 2015 Introduc*ons Background Onboarding
More informationHow Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
More informationLegacy Archiving How many lights do you leave on? September 14 th, 2015
Legacy Archiving How many lights do you leave on? September 14 th, 2015 1 Introductions Wendy Laposata, Himforma(cs Tom Chase, Cone Health 2 About Cone Health More than 100 loca=ons 6 hospitals, 3 ambulatory
More informationSupport from the CMS Innova2on Center for Rural ACOs
Support from the CMS Innova2on Center for Rural ACOs Hoangmai Pham, MD, MPH Director, Seamless Care Models Group CMS Innova
More information68 th Meeting of the National Cancer Institute (NCI) NCI Council of Research Advocates (NCRA) National Institutes of Health (NIH)
68 th Meeting of the National Cancer Institute (NCI) NCI Council of Research Advocates (NCRA) National Institutes of Health (NIH) Updates on NCI Programs Building 31, C Wing, Conference Room 6 NIH Campus
More informationReneaué Railton Sr. Informa2on Security Analyst, Duke Medicine Cyber Defense & Response
Reneaué Railton Sr. Informa2on Security Analyst, Duke Medicine Cyber Defense & Response Incident Response What is the most importance component of an Incident Response Program? Tools? Processes? Governance?
More informationThree Step Redirect API
Inspire Commerce &.pay Three Step Redirect API Inspire Commerce 800-261-3173 support@inspirecommerce.com Contents Overview... 3 Methodology... 3 XML Communica:on... 5 Transac:on Opera:ons... 6 Customer
More informationIma Okonny. Acting Director Data Management & Reporting Division Research and Evaluation Branch Citizenship and Immigration Canada
Ima Okonny Acting Director Data Management & Reporting Division Research and Evaluation Branch Citizenship and Immigration Canada Purpose & Outline Purpose: To describe CIC data holdings and highlight
More informationPES Has The Sustainable Solu2on For Chronic Care Management
PES Has The Sustainable Solu2on For Chronic Care Management Empowering pa2ents to lead the management of their chronic diseases through a proven and effec2ve model of collabora2on with clinicians and caregivers.
More informationPARTICIPATING IN CLINICAL TRIALS A GUIDE FOR PEOPLE WITH MS
PARTICIPATING IN CLINICAL TRIALS A GUIDE FOR PEOPLE WITH MS If you have ever taken a medication or received rehabilitative physical therapy, then you have experienced the benefits of clinical research.
More informationInformation Governance & Data Stewardship for an H.I.E. April 24, 2014
Information Governance & Data Stewardship for an H.I.E. April 24, 2014 1 15-03-30 Contents Governance vs. Data Stewardship The benefits of Governance & Data Stewardship Who does what? Key roles and activities
More informationStem cell research and the regula1on of clinical transla1on/applica1ons interna1onal viewpoints
Stem cell research and the regula1on of clinical transla1on/applica1ons interna1onal viewpoints Lars Ährlund Richter Department of woman and child health, Karolinska Ins1tutet, Sweden Presenta1on at The
More informationPa"ent Reported Outcomes Useful for Whom? Industry s Perspec/ve. Pri/ Jhingran, Ph.D. GlaxoSmithKline
Pa"ent Reported Outcomes Useful for Whom? Industry s Perspec/ve Pri/ Jhingran, Ph.D. GlaxoSmithKline AGENDA Why PROs? Applica0ons of PROs in Drug Development US Healthcare Reform Enhanced Value of PROs
More informationInterac(ve Broker (UK) Limited Webinar: Proprietary Trading Groups
Interac(ve Broker (UK) Limited Webinar: Proprietary Trading Groups Presenter Gerald Perez Managing Director London, United Kingdom E- mail: gperez@interac=vebrokers.com Important Informa=on: The risk of
More informationCLINES. 05.08.15 Cluster- based Innova6on through Embedded Systems technology
CLINES SWOT Analysis Smart Mobility 1 Smart Mobility in Bavaria Strong presence of automo>ve industry Ambi>ous research on mobility issues in Bavarian universi>es and research ins>tu>ons Prominent specializa>ons:
More informationTaking Part in Research at University Hospitals Birmingham
University Hospitals Birmingham NHS Foundation Trust The Trust provides free monthly health talks on a variety of medical conditions and treatments. For more information visit www.uhb.nhs.uk or call 0121
More informationCiviCRM Implementa/on Case Study
CiviCRM Implementa/on Case Study Leukaemia and Lymphoma Research www.leukaemialymphomaresearch.org.uk Parvez Saleh About the LLR Having gone through the socware/supplier selec/on process, the LLR decided
More informationNATIONAL FEDERAL GRANTS CONFERENCE & WEBCAST ADVANCING HIGHER EDUCATION, SCIENCE & OUTREACH
NATIONAL FEDERAL GRANTS CONFERENCE & WEBCAST ADVANCING HIGHER EDUCATION, SCIENCE & OUTREACH OCTOBER 21, 2011 MIAMI, FL Lawrence A. Tabak, DDS, PhD Principal Deputy Director, NaLonal InsLtutes of Health
More informationCancer Genomics: What Does It Mean for You?
Cancer Genomics: What Does It Mean for You? The Connection Between Cancer and DNA One person dies from cancer each minute in the United States. That s 1,500 deaths each day. As the population ages, this
More informationUrban Big Data Centre
Urban Big Data Centre Piyushimita Thakuriah (Vonu) Director, UBDC Professor and Ch2M Chair of Transport UNIVERSITY OF GLASGOW November 12, 2015 July 10, 2015 UBDC Partners Funded by ESRC Big Data Network
More informationAnthony Rodgers, Director Arizona Health Care Cost Containment System
Using Health Information Technology for State Medicaid/SCHIP Health System Transformation Anthony Rodgers, Director Arizona Health Care Cost Containment System National Vision of Health Information Exchange
More informationResults. Delivered! Implement your Big Data plan
Implement your Big Data plan Big Data Growth & Transformation Initiatives Goals for this session: Results. Delivered! Engage and energize the par4cipants Provide insights, lessons learned and recommenda4ons
More informationHow To Conduct A Clinical Trial In Brazil
Sonia Mansoldo Dainesi, MD, PhD, MBA Post-trial access to trial drugs: Legal, ethical and practical issues Brocher Founda-on, Geneva Dec 15-16 th, 2011 Poten-al conflicts of interest São Paulo University
More informationTaking E-Payment to the pan-european level
Taking E-Payment to the pan-european level John Broxis, Director MyBank SPIN, June, 11 th, 2013 1 What is MyBank? A new way to pay from your account using online or mobile banking MyBank launched 25 th
More informationCommon App Online: The Applicant Perspec5ve
Common App Online: The Applicant Perspec5ve Agenda This presenta,on looks at the processing life cycle of a student s applica,on from registra,on to submission. The CAO 2011-12 Common Applica,on Registra,on
More informationAccelerating Clinical Trials Through Shared Access to Patient Records
INTERSYSTEMS WHITE PAPER Accelerating Clinical Trials Through Shared Access to Patient Records Improved Access to Clinical Data Across Hospitals and Systems Helps Pharmaceutical Companies Reduce Delays
More information